Pre-hospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction

K Huber, RD Caterina, SD Kristensen… - European heart …, 2005 - academic.oup.com
Therapy of acute ST-elevation myocardial infarction (STEMI) has undergone dramatic
improvements during the past three decades, and in-hospital and 30-day mortality rates …

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

MS Sabatine, CP Cannon, CM Gibson… - … England Journal of …, 2005 - Mass Medical Soc
Background A substantial proportion of patients receiving fibrinolytic therapy for myocardial
infarction with ST-segment elevation have inadequate reperfusion or reocclusion of the …

Association of hemoglobin levels with clinical outcomes in acute coronary syndromes

MS Sabatine, DA Morrow, RP Giugliano, PBJ Burton… - Circulation, 2005 - Am Heart Assoc
Background—In the setting of an acute coronary syndrome (ACS), anemia has the potential
to worsen myocardial ischemia; however, data relating anemia to clinical outcomes in ACS …

Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials

G De Luca, H Suryapranata, GW Stone, D Antoniucci… - Jama, 2005 - jamanetwork.com
ContextThe benefits of abciximab in patients with ST-segment elevation myocardial
infarction (STEMI) are still a matter of debate. ObjectiveTo combine data from all randomized …

Significance of susceptibility vessel sign on T2*-weighted gradient echo imaging for identification of stroke subtypes

KH Cho, JS Kim, SU Kwon, AH Cho, DW Kang - Stroke, 2005 - Am Heart Assoc
Background and Purpose—In contrast to platelet-rich white thrombi, red thrombi in the heart
are rich in fibrin and trapped erythrocytes. The magnetic susceptibility effect of …

Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis …

JW Eikelboom, DJ Quinlan, SR Mehta, AG Turpie… - Circulation, 2005 - Am Heart Assoc
Background—There is uncertainty about the role of intravenous unfractionated heparin
(UFH) and low-molecular-weight heparin (LMWH) in patients with ST-elevation myocardial …

Antiplatelet therapy in neuroendovascular therapeutics

D Fiorella, L Thiabolt… - Neurosurgery …, 2005 - neurosurgery.theclinics.com
The rapid proliferation of catheter-based devices and neuroendovascular techniques has
resulted in an exponential growth in the spectrum of neurologic disease processes that are …

Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: an ENTIRE-TIMI 23 substudy

KK Ray, DA Morrow, CM Gibson, S Murphy… - European heart …, 2005 - academic.oup.com
Aims Prior studies suggest that acute coronary syndromes (ACSs) are associated with
endothelial activation and that this is of prognostic significance. We hypothesized that …

Stent-assisted angioplasty of symptomatic intracranial vertebrobasilar artery stenosis: feasibility and follow-up results

DJ Kim, BH Lee, DI Kim, WH Shim… - American Journal of …, 2005 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: The natural history of symptomatic, untreated posterior
circulation stenosis is dismal, with many patients experiencing significant morbidity or …

Design and rationale of Clopidogrel as Adjunctive Reperfusion therapy–thrombolysis in myocardial infarction (CLARITY-TIMI) 28 trial

MS Sabatine, CH McCabe, CM Gibson… - American Heart Journal, 2005 - Elsevier
BACKGROUND: Although fibrinolysis is effective in improving outcomes in ST-elevation
myocardial infarction (STEMI), failure to achieve reperfusion and/or reocclusion of the infarct …